Bezzerides, Vassilios J.
Zhang, Aifeng
Xiao, Ling
Simonson, Bridget
Khedkar, Santosh A.
Baba, Shiro
Ottaviano, Filomena
Lynch, Stacey
Hessler, Katherine
Rigby, Alan C.
Milan, David
Das, Saumya
Rosenzweig, Anthony
Article History
Received: 15 July 2016
Accepted: 27 February 2017
First Online: 23 March 2017
Competing Interests
: Drs Das, Milan and Rosenzweig have formed a company to develop SGK1 inhibitors for treatment of inherited arrhythmias. They have not received any compensation or research funding from the company. No other authors have any competing financial interests in this project.